Friday 6 November 2026 Export SOLV’s income statement to Excel — free account

Solventum Corporation

SOLV Healthcare Medical Instruments & Supplies

Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024.

Revenue: −7.01%
EPS: −101.0%
Free cash flow: +561.9%
Total debt: −90.1%

Quarter to September 2026, against a year earlier

90.48 3.30 +3.79%

Follow SOLV

Alert me

Market cap: $14.8B
P/E: 97.3×
Fwd P/E: 47.7×
Dividend yield: —
F-score: 5/9
Altman Z: 2.22
Beneish M: −2.07
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Solventum Corporation (SOLV) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Solventum Corporation (SOLV) trades at a P/E ratio of 97.3×. Over the past ten years it has ranged from 6.8× (June 2024) to 100× (November 2026); the current reading is higher than 98% of that period. That is above the Medical Instruments & Supplies industry median of 30.3× and above the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/SOLV/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Solventum Corporation P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/SOLV/metrics/pe-ratio">Solventum Corporation (SOLV) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	8.9×	(63.06%)
FY2024	24.0×	134.03%
FY2023	10.3×	0.00%
FY2022	10.3×	—

Period	P/E ratio	Change
Sep 2026	99.0×	955.29%
Jun 2026	9.4×	18.00%
Mar 2026	8.0×	(10.37%)
Dec 2025	8.9×	6.24%
11 more quarters	Free account

Against its own ten years

Low 6.8× High 100×

Ten-year median 10.6×

Current reading's percentile 98

Company	P/E ratio
RGEN Repligen Corporation compare	n/m
BAX Baxter International Inc. compare	n/m
BLCO Bausch + Lomb Corporation compare	n/m
COO The Cooper Companies, Inc. compare	21.7×
ALGN Align Technology, Inc. compare	23.1×
AVTR Avantor, Inc. compare	30.3×
ATR AptarGroup, Inc. compare	34.6×
WST West Pharmaceutical Services, Inc. compare	43.8×
SOLV Solventum Corporation	97.3×
Medical Instruments & Supplies industry median	30.3×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Solventum Corporation (SOLV) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on SOLV

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on SOLV

Stockrow Weekly